Controlled initial surge despite high drug fraction and high solubility

Pharmaceutical Development and Technology
Srilekha Sarkar DasDavid M Saylor

Abstract

Potential connections between release profiles and solvent evaporation rates alongside polymer chemistry were elucidated for the release of tetracycline hydrochloride from two different poly (d, l-lactide-co-glycolide) (PLGA) film matrices containing high drug fractions (50%, 30%, and 15%), and prepared at two distinct solvent evaporation rates. At highest tetracycline concentrations (50%), (i) the early release rates were ≤0.5 μg/min in all cases; (ii) release was linear from systems fabricated with lower lactic content and slower solvent evaporation rate and bimodal from systems fabricated with higher lactic content and faster evaporation rate; (iii) surface fractions covered by the drug were similar at both evaporation rates for 85:15 PLGA but very different for 50:50 PLGA, leading to unexpectedly reduced early release from 50:50 PLGA than from 85:15 PLGA when both the matrices were fabricated using a slower evaporation rate. These features remained unaffected in case of low drug concentration. Results suggested that during the formation of the drug-polymer microstructure, the combined effect of polymer chemistry and solvent evaporation rate sets apart the surface characteristics and the initial release profiles of systems c...Continue Reading

References

Feb 3, 1998·Journal of Pharmaceutical and Biomedical Analysis·D S Vienneau, C G Kindberg
Jun 26, 1998·Journal of Biomedical Materials Research·W L WebberE Mathiowitz
Jan 7, 1999·Drug Development and Industrial Pharmacy·R JainC T Rhodes
Apr 9, 1999·Drug Development and Industrial Pharmacy·J M BarichelloT Nagai
Jun 6, 2000·Advanced Drug Delivery Reviews·J W McGinity, P B O'Donnell
Jun 25, 2003·Circulation·Pedro A LemosJ Eduardo Sousa
Jan 22, 2004·Circulation·David P Faxon
May 6, 2004·Journal of Biomedical Materials Research. Part a·Amy C Richards GraysonRobert Langer
Sep 15, 2004·International Journal of Pharmaceutics·L P TanX T Wang
Nov 25, 2005·Current Drug Delivery·Mario Grassi, Gabriele Grassi
Sep 5, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Steven J SiegelNily Dan
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Robert A McLean, Robert I Garis
Mar 14, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·G MittalM N V Ravi Kumar
Sep 21, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Yoon Yeo, Daniel S Kohane
Feb 13, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Chang-Soo KimJames A Warren
May 13, 2009·Langmuir : the ACS Journal of Surfaces and Colloids·Jinping DongGreg Haugstad
Jun 6, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Marika KamberiDebra Feder
Jan 22, 2010·Journal of Pharmaceutical Sciences·Martin K McDermottCarolyn N Witkowski
Nov 9, 2010·International Journal of Pharmaceutics·D KloseJ Siepmann
Apr 5, 2011·International Journal of Pharmaceutics·Juergen Siepmann, Nicholas A Peppas
Jul 2, 2011·Nanomedicine·Elizabeth M SingerSteven S Smith
May 12, 2012·Polymers·Hirenkumar K Makadia, Steven J Siegel
Jan 1, 1984·Pharmaceutical Research·R A Siegel, R Langer

❮ Previous
Next ❯

Citations

Apr 25, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·UNKNOWN Fachübergreifender Arbeitskreis „Bundesweites Pollenmonitoring“

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.